Usher Live 1999

0 views

Skip to first unread message

Marcelene Vasconez

unread,

Aug 3, 2024, 5:59:45 PM8/3/24

to preeminopter

Live received generally negative reviews from critics; many criticized the poor live sound of Usher's voice on the album. Live reached number 73 on the Billboard 200, number 30 on the Top R&B Albums and number 3 on the Top Music Videos. The album has sold over 200,000 copies in the United States, and both the audio and video versions have been certified gold by the Recording Industry Association of America (RIAA).

Live was released in the United States by LaFace Records on March 23, 1999[4] by means of compact disc,[5] cassette[6] and VHS formats;[7] along with the concert footage, the VHS features interviews with Usher. The audio version Live was later serviced to digital retailers for music download.[8][9]

Live received generally negative reviews from music critics. Stephen Thomas Erlewine from Allmusic criticized Usher's "tired and weary" live sound, although he praised the remixed songs at the end of the album.[4] Entertainment Weekly's J. D. Considine gave Live a C grade and wrote that, despite Usher's performing ability, the audio album is boring without video footage of the concerts.[11] Neva Chonin of Rolling Stone was unimpressed with Usher's "tinny"-sounding voice on Live.[12]

Live debuted at number 76 on the US Billboard 200 on the chart dated April 10, 2011, with first-week sales of 21,000 copies.[1] The album peaked at number 73, and lasted nine weeks on the chart.[14] On April 27, 1999 Live was certified gold by the Recording Industry Association of America (RIAA), denoting the shipment of 500,000 units,[15] and by the end of 2001 Live had sold over 200,000 copies in the US.[1] It debuted and peaked at number 30 on the Top R&B Albums, and remained on that chart for nine weeks.[14] The video longform version of Live entered the US Top Music Videos chart at number four on the chart of April 10, 1999.[16] It remained at number four for three weeks,[17] before ascending to number three on May 1, 1999, where it peaked for one week.[18] The RIAA certified the Live video gold, after it shipped 50,000 copies, on December 22, 1999.[15] The video of the performance of "Bedtime" was made available at MTV.com,[19] and the live version of "Bedtime" reached number 66 on the Hot R&B/Hip-Hop Singles & Tracks chart.[20]

My Way offered Usher new opportunities to extend his status as a popular celebrity. In 1998 Usher briefly stopped recording to appear in several feature films, most notably Light It Up (1999), in which he plays the lead. During that time he also appeared on the covers of numerous music and popular-culture magazines. Usher released a collection of live recordings entitled Live in 1999 before returning to the studio to record All About U.

Usher, a native of Chattanooga, Tennessee, began his recording career in 1994 with Atlanta-based LaFace Records. In 2001 the artist received two Grammy awards. Usher has also starred in several feature films.

The New Georgia Encyclopedia does not hold the copyright for this media resource and can neither grant nor deny permission to republish or reproduce the image online or in print. All requests for permission to publish or reproduce the resource must be submitted to the Atlanta Journal-Constitution.

Usher Raymond IV born October 14, 1978 born in Dallas, Texas Usher was raised in Chattanooga, TN with his younger brother James, by his mother (single) Jonnetta Patton.height: 5"9Usher began to sing around the age of 9 in his church choir at St. Elmoes M.B. Church. His mother realized that he had a passion for singing when he was young and decided to move to Atlanta, Georgia where there were more music career opportunities. In Atlanta, Usher's mother entered him into numerous talent contests and shows. Usher even appeared on the hit tv show Star Search around the age of 12. Usher had a dream of becoming a star and that dream came true when he was introduced to Laface Records CEO L.A. Reid. Usher was quickly signed to the label after singing once for L.A. Reid and a few other employees. Usher's first studio production was for the Poetic Justice Soundtrack - the song was entitled "Just Call Me A Mack". Usher's first album "Usher" executive produced by P.Diddy was released in 1994 and included the hit song "Think Of You".
In 1997 Usher was also introduced to acting when he landed his first role on the UPN sitcom Moesha. He also had roles in The Parenthood, The Bold & The Beautiful, Sabrina, The Faculty (movie), She's All That (movie), Texas Rangers (movie) & Light It Up (movie). In 1999 Usher released a live concert album and video (Usher Live).
Usher released "8701" on August 7th, 2001. The album's title stands for Usher's growth as an artist from 1987-2001. On this record he was able to show his vocal growth and growth as an artist all around. 8701 also went multiplatinum and led to Usher's superstar status. Usher lived with Sean "P Diddt" Combs during the production of his first album "Usher".He owns a Harley Davidson motorcycleFavorite flower: OrchidFavorite book: Conversations with GodHe has his own record label now and has done duets with Monica and Mariah Carey

"This is still just the beginning...I feel like I've accomplished so much already, but I still have my whole life ahead of me and much more to do. I'm learning to play instruments, I want to get into acting...I'm open to do so much."

Usher syndrome type I (USH1) is characterized by congenital, bilateral, profound sensorineural hearing loss, vestibular areflexia, and adolescent-onset retinitis pigmentosa (RP). Unless fitted with a cochlear implant, individuals do not typically develop speech. RP, a progressive, bilateral, symmetric degeneration of rod and cone functions of the retina, develops in adolescence, resulting in progressively constricted visual fields and impaired visual acuity.

Treatment of manifestations: In infants: an initial trial of hearing aids to stimulate residual hearing and accustom the infant to auditory stimulation. Cochlear implantation should be considered as young as medically feasible. Sign language and tactile signs (once visual loss occurs) for families who choose non-auditory communication. Specialized training from educators of the hearing impaired. Vestibular compensation therapy for children with residual balance function and sensory substitution therapy for individuals with complete absence of vestibular function. Standard treatments for retinitis pigmentosa.

Surveillance: Annual audiometry and tympanometry in those with cochlear implant or hearing aids to assure adequate auditory stimulation. Annual otoscopic exam with tympanometry in children with profound loss to evaluate for chronic otitis media. Annual ophthalmologic evaluation, fundus photography, visual acuity, visual field testing, electroretinography, optical coherence tomography, and fundus autofluorescence from age 20 years.

Agents/circumstances to avoid: Competition in sports requiring acute vision and/or good balance may be difficult and possibly dangerous. Because of the high risk for disorientation when submerged in water, swimming needs to be undertaken with caution. Progressive loss of peripheral vision impairs the ability to safely drive a car.

USH1 is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once the USH1-causing pathogenic variants have been identified in an affected family member, carrier testing for at-risk relatives, prenatal diagnosis for a pregnancy at increased risk, and preimplantation genetic testing are possible.

The diagnosis of USH1 is established in a proband with the above clinical features and family history. Identification of biallelic pathogenic (or likely pathogenic) variants in one of the genes listed in Table 1 establishes the diagnosis if clinical features are inconclusive.

Note: (1) Per ACMG/AMP variant interpretation guidelines, the terms "pathogenic variants" and "likely pathogenic variants" are synonymous in a clinical setting, meaning that both are considered diagnostic and both can be used for clinical decision making [Richards et al 2015]. Reference to "pathogenic variants" in this section is understood to include any likely pathogenic variants. (2) Identification of biallelic variants of uncertain significance (or of one known pathogenic variant and one variant of uncertain significance) in one of the genes listed in Table 1 does not establish or rule out the diagnosis.

The phenotype of USH1 is often indistinguishable from many other inherited disorders associated with hearing loss and/or RP; therefore, the recommended molecular genetic testing approaches include use of a multigene panel or comprehensive genomic testing.

An Usher syndromemultigene panel or a more comprehensive multigene panel (e.g., inherited retinal dystrophy panel, hereditary hearing loss panel) that includes the genes listed in Table 1 and other genes of interest (see Differential Diagnosis) is most likely to identify the genetic cause of the condition while limiting identification of variants of uncertain significance and pathogenic variants in genes that do not explain the underlying phenotype. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this GeneReview. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused exome analysis that includes genes specified by the clinician. (4) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing-based tests.